The use of anisoin as pre-chromatographic reagent for LC analysis of guanidino compounds is proposed. The reagent reacts (5 min at 100°C) with guanidino function and the resulting adducts can be chromatographed under reversed-phase conditions. A fluorescence detector (lex = 325 nm; lem = 435 nm) was used to detect guanidino adducts. The derivatization and chromatographic conditions were optimised by a series of experiments. Application to the determination of arginine and creatine in pharmaceuticals and arginine, guanidine, methylguanidine, guanidinosuccinic acid, b-guanidinopropionic acid, g-guanidinobutyric acid, guanidinoacetic acid and homoarginine in human urine is described. Quantitation limits ranged from 6 to 30 fmol, except for creatine (510 fmol).

R.Gatti, M.G.Gioia (2006). Anisoin: A useful pre-chromatographic derivatization fluorogenic reagent for LC analysis of guanidino compounds. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 42, 11-16 [10.1016/j.jpba.2005.12.035].

Anisoin: A useful pre-chromatographic derivatization fluorogenic reagent for LC analysis of guanidino compounds

GATTI, RITA;GIOIA, MARIA GRAZIA
2006

Abstract

The use of anisoin as pre-chromatographic reagent for LC analysis of guanidino compounds is proposed. The reagent reacts (5 min at 100°C) with guanidino function and the resulting adducts can be chromatographed under reversed-phase conditions. A fluorescence detector (lex = 325 nm; lem = 435 nm) was used to detect guanidino adducts. The derivatization and chromatographic conditions were optimised by a series of experiments. Application to the determination of arginine and creatine in pharmaceuticals and arginine, guanidine, methylguanidine, guanidinosuccinic acid, b-guanidinopropionic acid, g-guanidinobutyric acid, guanidinoacetic acid and homoarginine in human urine is described. Quantitation limits ranged from 6 to 30 fmol, except for creatine (510 fmol).
2006
R.Gatti, M.G.Gioia (2006). Anisoin: A useful pre-chromatographic derivatization fluorogenic reagent for LC analysis of guanidino compounds. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 42, 11-16 [10.1016/j.jpba.2005.12.035].
R.Gatti; M.G.Gioia
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/31585
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 15
social impact